902454-26-6

Basic information

• Product Name: 4-[(1-METHYL-4-PIPERIDINYL)METHOXY]BENZENAMINE
• Synonyms: 4-[(1-METHYL-4-PIPERIDINYL)METHOXY]BENZENAMINE;4-[(1-METHYLPIPERIDINE-4-YL)METHOXY]PHENYLAMINE;4-(1-Methyl-4-piperidinylMethoxy)aniline, 96%;4-[(1-Methylpiperidin-4-yl)methoxy]aniline
• CAS NO: 902454-26-6
• Molecular Formula: C₁₃H₂₀N₂O
• Molecular Weight: 220.31
• Mol File: 902454-26-6.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 352.986°C at 760 mmHg
• Flash Point: 167.28°C
• Appearance: /
• Density: 1.053g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.549
• CAS DataBase Reference: 4-[(1-METHYL-4-PIPERIDINYL)METHOXY]BENZENAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[(1-METHYL-4-PIPERIDINYL)METHOXY]BENZENAMINE(902454-26-6)
• EPA Substance Registry System: 4-[(1-METHYL-4-PIPERIDINYL)METHOXY]BENZENAMINE(902454-26-6)

Safety Data

• HazardClass: 6.1
• Hazardous Substances Data: 902454-26-6(Hazardous Substances Data)

Usage

InChI:InChI=1/C13H20N2O/c1-15-8-6-11(7-9-15)10-16-13-4-2-12(14)3-5-13/h2-5,11H,6-10,14H2,1H3

Upstream product

• 902454-25-5 1-methyl-4-[(4-nitrophenoxy)methyl]piperidine 
• 20691-89-8 1-methyl-4-piperidinemethanol 
• 1126-09-6 4-carbethoxypiperidine 
• 24252-37-7 ethyl 1-methylisonipecotate 

Downstream Products

• 957345-26-5 (5-bromo-imidazo[1,2-a]pyrazin-8-yl)-[4-(1-methyl-piperidin-4-ylmethoxy)-phenyl]-amine 
• 1202759-92-9 C₂₈H₃₅FN₆O₃ 

Relevant articles and documents

Water-Soluble CC-1065 Analogs and Their Conjugates

This invention relates to novel analogs of the DNA-binding alkylating agent CC-1065 and to their conjugates. Furthermore this invention concerns intermediates for the preparation of said agents and their conjugates. The conjugates are designed to release their (multiple) payload after one or more activation steps and/or at a rate and time span controlled by the conjugate in order to selectively deliver and/or controllably release one or more of said DNA alkylating agents. The agents, conjugates, and intermediates can be used to treat an illness that is characterized by undesired (cell) proliferation. As an example, the agents and the conjugates of this invention may be used to treat a tumor.

IMIDAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

Novel imidazo[1,2-a]pyrazine compounds are disclosed that have a formula ( I ) represented by the following:The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, arthritis, inflammation, and others.